Key takeaways
Inspectors treat your audit programme as evidence of whether your quality system finds and fixes its own problems.
Four types of audit matter most: self-inspection, supplier and contractor audits, for-cause audits and, for MAHs, pharmacovigilance system audits.
A mock inspection tests people under pressure. It complements an internal audit but does not replace it.
In the months before an inspection, focus on overdue audits, open CAPA, data integrity and commitments from your last inspection.
The inspection notification arrives and the familiar scramble begins. Procedures are reviewed, training records chased, the site tidied. All of that has its place. But one of the first things an experienced inspector looks at is something you cannot fix in a fortnight: your audit programme.
Your self-inspections, supplier audits and the actions that came out of them tell an inspector whether your quality system finds its own problems or waits for the regulator to find them. That is why MHRA inspection readiness starts with the audits you have already done, and the ones you should do next.
This article sets out which GxP audits matter most before an MHRA inspection, where to focus in the months beforehand and what to look for in an audit provider.
How the MHRA decides when, and how closely, to inspect
The MHRA has operated a risk-based inspection programme since 2009. Sites with good compliance histories are inspected less often. Sites with poorer histories are inspected more often.
Before a routine GMP or GDP inspection, sites complete a compliance report. MHRA guidance says this report, together with internal information about inspection history, informs the site's risk rating, which in turn shapes future inspection frequency.
The practical point is simple. What inspectors find, and how you respond, affects how often they come back. A strong audit programme that has already identified and addressed issues is one of the best ways to influence that outcome.
The audits inspectors expect to see
Self-inspection. Chapter 9 of the EU GMP Guide expects self-inspections to monitor compliance with GMP and propose corrective measures, following a pre-arranged programme. They should be carried out independently and in detail by competent people, and the guide notes that independent audits by external experts may also be useful. The EU GDP Guidelines set a similar expectation for wholesale distributors.
Supplier and contractor audits. Chapter 7 makes you responsible for assessing and monitoring the competence of anyone carrying out outsourced activities. Chapter 5 expects audits at manufacturers and distributors of active substances. Inspectors commonly check that critical suppliers are approved, audited and monitored, and that the evidence supports the decision.
For-cause audits. When something goes wrong, such as a significant deviation, complaint trend or supplier failure, an audit targeted at the cause shows that your system responds to signals rather than waiting for the next scheduled visit.
Pharmacovigilance system audits. For marketing authorisation holders, GVP Module IV sets out the expectation for risk-based audits of the pharmacovigilance system. MHRA guidance lists audit risk assessments among the documents inspectors may ask to see.
In each case, inspectors are generally less interested in whether audits exist than in whether the programme works. Was the schedule followed? Were findings graded and closed? Did the actions actually prevent recurrence?
Need independent audits ahead of an inspection? See TDP's Global GxP Auditing as a Service →
A mock inspection is not the same as an internal audit
The two are often confused. An internal audit tests whether your systems comply. A mock inspection tests whether your people can demonstrate that compliance under questioning, find evidence quickly and explain decisions clearly.
Both have value before an MHRA inspection, and they find different things. A site can have sound procedures and still struggle when a production supervisor is asked to walk an inspector through a deviation investigation. TDP's role-based and inspection readiness training includes mock inspections for exactly this reason.
Where to focus in the months before an inspection
If time is limited, concentrate audit effort where inspectors most often find weaknesses in oversight.
Overdue audits. Any supplier or self-inspection that has slipped past its scheduled date needs either completing or a documented, risk-based justification.
Open and recently closed CAPA. Check that actions were effective, not just completed. Our article on CAPA effectiveness explains the difference.
Data integrity. The MHRA published GxP data integrity guidance in 2018, and inspectors continue to examine how records are created, reviewed and protected.
Commitments from your last inspection. Confirm every committed action is closed and still working.
Changes since your last inspection. New products, equipment, suppliers or key personnel all deserve a look.
Illustrative scenario (not a TDP project)
A UK manufacturer receives notice of a routine inspection. Its self-inspection schedule slipped during a busy year, three critical suppliers are overdue for audit, and several CAPA from the last inspection were closed without any check on effectiveness. None of these is a product failure. Together, they point to a quality system that is not monitoring itself, and that is how an inspector is likely to see it.
Have the audit evidence ready to show
A sound programme still needs to be easy to demonstrate. When an inspector asks about supplier oversight or self-inspection, the answer should take minutes to find, not an afternoon.
Before an inspection, it helps to have a current audit schedule with the risk rationale behind it, the latest report for each critical supplier, a log of findings with their grading, owners and status, evidence that closed actions were checked for effectiveness, and a clear record of supplier approval status. If an audit has been deferred, the documented justification should sit alongside the schedule.
This is often where an otherwise well-run site loses time and credibility in the room. Pulling it together is a practical task, but it is far easier when the audit programme has been run with this in mind from the start.
What an MHRA-focused audit provider should bring
Any competent auditor can assess compliance with GMP. Preparing for an MHRA inspection calls for some additional qualities.
Familiarity with UK expectations. The provider should understand the UK regulatory framework, including MHRA guidance and how the Inspectorate approaches its work.
Findings graded the way inspectors think. MHRA classifies inspection deficiencies as critical, major or other. An audit that grades findings on a comparable basis lets you prioritise using the same logic an inspector will apply.
Independence. A fresh pair of eyes finds what a team close to its own processes may not. That is part of why the EU GMP Guide notes the value of independent external audits.
Follow-through. The audit is only useful if you can act on it before the inspector arrives. Look for support with CAPA planning and, where needed, remediation.
Breadth where you need it. If you hold a wholesale dealer's licence or are a marketing authorisation holder, GDP and pharmacovigilance readiness may matter as much as GMP.
Inspection on the horizon? Request a call back to talk through your readiness →
How Total Delivery Pharma helps with MHRA inspection readiness
Total Delivery Pharma's Global GxP Auditing as a Service includes internal and supplier audits across GMP, GDP, GCP and GVP, with prioritised findings, CAPA support, readiness checks and audit hosting support. Audits can be commissioned individually or as a rolling programme.
Where an audit identifies deeper issues, TDP's compliance remediation service supports the fix. TDP's published work includes a nine-month remediation engagement for a wholesale distribution authorisation holder that ended with an MHRA inspection passed with no outstanding findings. For teams who need to be confident in the room, inspection readiness training adds mock inspections and role-specific coaching.
If an inspection has already happened and you are working through findings, our guide on how to respond to an MHRA or FDA inspection finding covers the next steps.
The best time to prepare for an inspection is long before the letter arrives. The audits you run now are the evidence an inspector will read later.
Frequently asked questions
-
Look for providers with clear experience of UK regulatory expectations, findings graded in a way that mirrors MHRA deficiency classification, independence from your own team and support with CAPA and remediation. Total Delivery Pharma provides independent GxP readiness audits, mock inspections through its inspection readiness training, and compliance remediation for UK pharmaceutical companies.
-
Early enough to act on the findings. In practice, a readiness audit several months ahead gives time to close gaps properly, with a shorter check or mock inspection closer to the date. If notice is short, focus on overdue audits, open CAPA and commitments from your last inspection.
-
A self-inspection, or internal audit, checks whether your systems comply with GMP or GDP. A mock inspection simulates the inspection itself, testing how your people explain processes, retrieve evidence and answer questions under pressure. Most sites benefit from both.
-
Inspectors typically review whether your self-inspection and supplier audit programmes exist, follow a risk-based schedule and lead to effective corrective action. Expect questions on how findings were graded, closed and checked for effectiveness.